Snehal Patel
CEO, CFO at Greenwich LifeSciences, Inc. (GLSI)
Purchase track record
Strong record. Based on 8 purchases with a full 90 days of price history.
100
Avg. 90-day return+107.2%
vs. S&P 500+107.5%
Beat the market75%
Paper profit on buys+$88K
Total bought / sold$586K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 30SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 1,5005,610,702 held (+0%) | $13.59 | $20K | +21.6% |
| Jul 30SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 7005,611,402 held (+0%) | $13.10 | $9K | +26.2% |
| Jul 29SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 1,5005,609,202 held (+0%) | $13.62 | $20K | +21.4% |
| Jul 27SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 2,5005,606,602 held (+0%) | $13.14 | $33K | +25.8% |
| Jul 27SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 1,1005,607,702 held (+0%) | $12.88 | $14K | +28.3% |
| Jan 15SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 1,8005,604,102 held (+0%) | $29.83 | $54K | -44.6% |
| Jan 14SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 2,9005,602,302 held (+0%) | $27.54 | $80K | -40.0% |
| Jan 5SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 4,3005,599,402 held (+0%) | $21.36 | $92K | -22.6% |
| Jan 2SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 2,9005,595,102 held (+0%) | $21.73 | $63K | -23.9% |
| Dec 19SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 4,1005,592,202 held (+0%) | $12.62 | $52K | +31.0% |
| Nov 28SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 4,6005,588,102 held (+0%) | $8.37 | $39K | +97.5% |
| Nov 12SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 10,6005,583,502 held (+0%) | $8.43 | $89K | +96.1% |
| Nov 4SEC | GLSIGreenwich LifeSciences, Inc. | Buy | 2,3005,572,902 held (+0%) | $9.26 | $21K | +78.5% |
- Buy
CEO, CFO Snehal Patel bought $89K of GLSI at $8.43 — largest purchase by this insider in our records.
- Buy
CEO, CFO Snehal Patel bought $21K of GLSI at $9.26 — first open-market purchase in our records.